Jerusalem Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	49.93	39.82	39.65	46.14	46.23
Revenue Growth (YoY)	25.39%	0.42%	-14.06%	-0.18%	27.00%
Cost of Revenue	22.56	19.7	18.31	23	23.44
Gross Profit	27.37	20.12	21.34	23.14	22.79
Selling, General & Admin	12.42	10.52	10.77	12.23	12.57
Research & Development	1.4	1.12	0.93	1.73	1.74
Other Operating Expenses	-0.14	-0.09	-0.15	-0.26	0.07
Operating Expenses	14.47	13.42	12.36	14.33	14.81
Operating Income	12.89	6.7	8.98	8.81	7.98
Interest Expense	-0.28	-0.02	-0.04	-0.06	-0.06
Interest & Investment Income	-	-	-	0.03	0.02
Earnings From Equity Investments	-	-	-	-	-0
Currency Exchange Gain (Loss)	-1.17	-0.64	-0.08	0.36	-0.21
Other Non Operating Income (Expenses)	-	-0.29	-0.19	-0.14	-0.16
EBT Excluding Unusual Items	11.44	5.76	8.68	9	7.57
Gain (Loss) on Sale of Investments	1.59	0.84	0.04	0	0
Gain (Loss) on Sale of Assets	-	0	0.11	-	0.01
Other Unusual Items	-	0.02	-	0.03	0.04
Pretax Income	13.03	6.62	8.82	9.03	7.62
Income Tax Expense	2.72	1.56	1.81	1.82	1.4
Earnings From Continuing Operations	10.31	5.06	7.01	7.21	6.22
Earnings From Discontinued Operations	-	-	-	-0.21	-
Net Income to Company	10.31	5.06	7.01	7	6.22
Minority Interest in Earnings	-0.07	-0.02	-0.05	0.17	0.38
Net Income	10.23	5.04	6.96	7.17	6.6
Net Income to Common	10.23	5.04	6.96	7.17	6.6
Net Income Growth	103.10%	-27.58%	-3.02%	8.73%	77.11%
Shares Outstanding (Basic)	36	36	36	36	36
Shares Outstanding (Diluted)	36	36	36	36	36
Shares Change (YoY)	0.08%	-	-	-	-
EPS (Basic)	0.28	0.14	0.19	0.20	0.18
EPS (Diluted)	0.28	0.14	0.19	0.20	0.18
EPS Growth	102.95%	-27.58%	-3.02%	8.73%	77.11%
Free Cash Flow	1.48	9.94	7.84	16.32	3.86
Free Cash Flow Per Share	0.04	0.28	0.22	0.45	0.11
Dividend Per Share	-	0.040	0.050	0.075	0.060
Dividend Growth	-	-20.00%	-33.33%	25.00%	50.00%
Gross Margin	54.81%	50.52%	53.82%	50.15%	49.30%
Operating Margin	25.82%	16.83%	22.65%	19.09%	17.25%
Profit Margin	20.49%	12.65%	17.54%	15.55%	14.27%
Free Cash Flow Margin	2.97%	24.96%	19.77%	35.37%	8.35%
EBITDA	14.77	7.95	10.17	10.53	9.94
EBITDA Margin	29.57%	19.95%	25.65%	22.83%	21.50%
D&A For EBITDA	1.87	1.24	1.19	1.73	1.96
EBIT	12.89	6.7	8.98	8.81	7.98
EBIT Margin	25.82%	16.83%	22.65%	19.09%	17.25%
Effective Tax Rate	20.90%	23.52%	20.55%	20.18%	18.42%
Advertising Expenses	-	0.02	0.01	0.06	0.05

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.